Dermatitis, Atopic – Page 2 – Talk Bio

Actionable Insights Powered by AI

Almirall’s Ebglyss Gains NICE Recommendation for Atopic Dermatitis Treatment

10 months ago talkbio0Tagged Biological Response Modifier Therapy, Dermatitis, Atopic, Ebglyss, England, lebrikizumab, Moderate (severity modifier), Nance-Horan syndrome, Nitroglycerin/Sodium Citrate/Ethanol Solution, Recommendation, Severe (severity modifier)

Ebglyss, lebrikizumab, atopic dermatitis, NICE recommendation, Almirall, NHS England, biological therapy, moderate to severe atopic dermatitis

Arcutis Biotherapeutics Secures FDA Approval for ZORYVE Cream to Treat Atopic Dermatitis

10 months ago talkbio0Tagged Approved, Arcutis, biotherapeutics, Dermatitis, Atopic, Roflumilast Cream, Steroid-Free, United States Food and Drug Administration, Zoryve

Arcutis Biotherapeutics, ZORYVE, Atopic Dermatitis, FDA Approval, Roflumilast Cream, Steroid-Free Treatment

Johnson & Johnson Expands Dermatology Portfolio with $850M Acquisition of Proteologix

11 months ago talkbio0Tagged Acquisition (action), bispecifics, Dermatitis, Atopic, J&J, Johnson and Johnson, Proteologix

Johnson & Johnson, J&J, Proteologix, atopic dermatitis, bispecifics, pipeline, acquisition, $850M

Sanofi Eyes COPD Treatment as Major Growth Driver for Dupixent, Says CEO

12 months ago talkbio0Tagged Asthma, CEO, Chronic Obstructive Airway Disease, Clinical Trials, Dermatitis, Atopic, Dupixent, expansion, growth pillar, Immunology, sanofi

Sanofi, Dupixent, COPD, growth pillar, immunology, CEO, treatment, expansion, clinical trials, asthma, atopic dermatitis.